Terms: = Liver cancer AND BCL11B, CTIP-2, 64919, ENSG00000127152, CTIP2, hRIT1-alpha, Q9C0K0
4 results:
1. bcl11b expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.
Abe H; Kamimura K; Okuda S; Watanabe Y; Inoue J; Aoyagi Y; Wakai T; Kominami R; Terai S
Cancer Med; 2023 Jul; 12(14):15650-15663. PubMed ID: 37293953
[TBL] [Abstract] [Full Text] [Related]
2. bcl11b suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity.
Yang WJ; Sun YF; Jin AL; Lv LH; Zhu J; Wang BL; Zhou Y; Zhang CY; Wang H; Hu B; Wang PX; Te L; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Cell Death Dis; 2020 Oct; 11(10):895. PubMed ID: 33093445
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in cancer Patients Based on Transcriptomic Profiling.
Karim S; Mirza Z; Chaudhary AG; Abuzenadah AM; Gari M; Al-Qahtani MH
Int J Mol Sci; 2016 Feb; 17(2):250. PubMed ID: 26907258
[TBL] [Abstract] [Full Text] [Related]
4. bcl11b is essential for group 2 innate lymphoid cell development.
Walker JA; Oliphant CJ; Englezakis A; Yu Y; Clare S; Rodewald HR; Belz G; Liu P; Fallon PG; McKenzie AN
J Exp Med; 2015 Jun; 212(6):875-82. PubMed ID: 25964370
[TBL] [Abstract] [Full Text] [Related]
